Serum autotaxin levels in responders to HCV treatment by direct-acting antivirals
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2090-6226
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Serum autotaxin levels in responders to HCV treatment by direct-acting antivirals ; volume:10 ; number:1 ; day:26 ; month:8 ; year:2020 ; pages:1-4 ; date:12.2020
Egyptian liver journal ; 10, Heft 1 (26.8.2020), 1-4, 12.2020
- Creator
-
Ahmed, Nancy Abdel Fattah
Deiab, Ahmed Galal
Hasan, Ahmad Shawki Mohammad
Elbaky, Ahmad Mohamed Yousry Abd
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s43066-020-00051-x
- URN
-
urn:nbn:de:101:1-2020101422022572667946
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:49 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Ahmed, Nancy Abdel Fattah
- Deiab, Ahmed Galal
- Hasan, Ahmad Shawki Mohammad
- Elbaky, Ahmad Mohamed Yousry Abd
- SpringerLink (Online service)
Other Objects (12)
Long term changes in thrombocytopenia and leucopenia after HCV eradication with direct-acting antivirals
Direct-acting antivirals and visceral leishmaniasis: a case report
Effect of eradication of HCV infection by direct-acting antivirals in diabetic HCV-infected patients as regards glycemic control
Impact of HCV eradication following direct-acting antivirals on liver stiffness measurement: a prospective longitudinal study
A systematic review of sofosbuvir/velpatasvir/voxilaprevir in HCV patients previously treated with direct-acting antivirals
Direct-acting antivirals used in HCV-related liver disease do not affect thyroid function and autoimmunity
Drug–Drug Interactions Between Direct-Acting Antivirals and Psychoactive Medications
Simple Predictive Markers and Clinicopathological Features of Primary Liver Cancer following HCV Clearance with Direct-Acting Antivirals
Proteomics reveals a global phenotypic shift of NK cells in HCV patients treated with direct‐acting antivirals
Efficacy and safety of direct-acting antivirals for HCV in patients with extrahepatic malignancies: real-life experience
Economic Evaluation of Direct-Acting Antivirals for Hepatitis C in Norway
Effect of sustained virological response after direct-acting antivirals on liver fibrosis in patients with chronic HCV infection
Long term changes in thrombocytopenia and leucopenia after HCV eradication with direct-acting antivirals
Direct-acting antivirals and visceral leishmaniasis: a case report
Effect of eradication of HCV infection by direct-acting antivirals in diabetic HCV-infected patients as regards glycemic control
Impact of HCV eradication following direct-acting antivirals on liver stiffness measurement: a prospective longitudinal study
A systematic review of sofosbuvir/velpatasvir/voxilaprevir in HCV patients previously treated with direct-acting antivirals
Direct-acting antivirals used in HCV-related liver disease do not affect thyroid function and autoimmunity
Drug–Drug Interactions Between Direct-Acting Antivirals and Psychoactive Medications
Simple Predictive Markers and Clinicopathological Features of Primary Liver Cancer following HCV Clearance with Direct-Acting Antivirals
Proteomics reveals a global phenotypic shift of NK cells in HCV patients treated with direct‐acting antivirals
Efficacy and safety of direct-acting antivirals for HCV in patients with extrahepatic malignancies: real-life experience
Economic Evaluation of Direct-Acting Antivirals for Hepatitis C in Norway
Effect of sustained virological response after direct-acting antivirals on liver fibrosis in patients with chronic HCV infection
Long term changes in thrombocytopenia and leucopenia after HCV eradication with direct-acting antivirals
Direct-acting antivirals and visceral leishmaniasis: a case report
Effect of eradication of HCV infection by direct-acting antivirals in diabetic HCV-infected patients as regards glycemic control
Impact of HCV eradication following direct-acting antivirals on liver stiffness measurement: a prospective longitudinal study
A systematic review of sofosbuvir/velpatasvir/voxilaprevir in HCV patients previously treated with direct-acting antivirals
Direct-acting antivirals used in HCV-related liver disease do not affect thyroid function and autoimmunity
Drug–Drug Interactions Between Direct-Acting Antivirals and Psychoactive Medications
Simple Predictive Markers and Clinicopathological Features of Primary Liver Cancer following HCV Clearance with Direct-Acting Antivirals
Proteomics reveals a global phenotypic shift of NK cells in HCV patients treated with direct‐acting antivirals
Efficacy and safety of direct-acting antivirals for HCV in patients with extrahepatic malignancies: real-life experience
Economic Evaluation of Direct-Acting Antivirals for Hepatitis C in Norway